Variables associated with extra uterine growth restriction in very low birth weight infants

Paola Azara Tabicas Lima1, Manoel de Carvalho1, Ana Carolina Carioca da Costa2

  • 1Clínica Perinatal Laranjeiras, Rio de Janeiro, RJ, Brazil; Instituto Fernandes Figueira/FIOCRUZ, Rio de Janeiro, RJ, Brazil; Universidade Federal Fluminense (UFF), Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|October 26, 2013
PubMed

Insights

Extrauterine growth restriction affects over a quarter of very low birth weight infants, particularly those small for gestational age. Neonatal morbidities also significantly impact growth outcomes in these vulnerable newborns.

Area of Science:

  • Neonatology
  • Pediatric Growth and Development
  • Perinatal Medicine

Background:

  • Extrauterine growth restriction (EUGR) is a significant concern in preterm infants.
  • Identifying risk factors for EUGR is crucial for improving neonatal outcomes.

Purpose of the Study:

  • To determine the incidence of extrauterine growth restriction (EUGR) in very low birth weight (VLBW) infants.
  • To evaluate the influence of perinatal variables, clinical practices, and neonatal morbidities on EUGR.

Main Methods:

  • Longitudinal study in four neonatal units in Rio de Janeiro.
  • Analyzed 570 very low birth weight infants, including perinatal, clinical, and morbidity data.
  • Defined EUGR using z-scores for weight or head circumference ≤ -2 for corrected age.

Main Results:

  • The incidence of EUGR based on weight was 26% (149/570); based on head circumference, it was 5% (29/570).
  • Infants small for gestational age (SGA) showed the highest impact on both weight (PR=4.33) and head circumference (PR=2.11) growth restriction.
  • Mean z-scores at discharge indicated growth deficits for both weight and head circumference.

Conclusions:

  • Extrauterine growth restriction (EUGR) is highly prevalent in VLBW infants.
  • Small for gestational age (SGA) status and neonatal morbidities are significant risk factors for EUGR.
  • Interventions targeting SGA infants and managing neonatal morbidities are essential to reduce EUGR.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
58.8K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K